Substrates for peptidase M13.001: neprilysin
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Gln-EDDnp | Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro+Tyr-Gln-EDDnp | S | Pro | Arg | Arg | Pro | Tyr | Gln | EDD | - | Oliveira et al., 2001 | |||||
| Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Gln-EDDnp | Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro+Tyr-Ile-Gln-EDDnp | S | Pro | Arg | Arg | Pro | Tyr | Ile | Gln | EDD | Oliveira et al., 2001 | |||||
| Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Gln-EDDnp | Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Gln-EDDnp | S | Arg | Arg | Pro | Tyr | Ile | Gln | EDD | - | Oliveira et al., 2001 | |||||
| Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro+Tyr-Ile-Leu-Gln-EDDnp | S | Pro | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | Oliveira et al., 2001 | |||||
| Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Leu-Gln-EDDnp | S | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | EDD | Oliveira et al., 2001 | |||||
| Abz-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro+Tyr-Ile-Leu-Gln-EDDnp | S | Pro | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | Oliveira et al., 2001 | |||||
| Abz-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Leu-Gln-EDDnp | S | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | EDD | Oliveira et al., 2001 | |||||
| Abz-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Lys-Pro-Arg-Arg-Pro+Tyr-Ile-Leu-Gln-EDDnp | S | Pro | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | Oliveira et al., 2001 | |||||
| Abz-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-Gln-EDDnp | Abz-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Leu-Gln-EDDnp | S | Arg | Arg | Pro | Tyr | Ile | Leu | Gln | EDD | Oliveira et al., 2001 | |||||
| angiotensin-1 | P01019 | 34-43 | Asp-Arg-Val-Tyr-Ile-His-Pro+Phe-His-Leu | P | LC | Tyr | Ile | His | Pro | Phe | His | Leu | - | Stewart et al., 1981 | ||
| angiotensin-1 | P01019 | 34-43 | Asp-Arg-Val-Tyr+Ile-His-Pro-Phe-His-Leu | P | LC | Asp | Arg | Val | Tyr | Ile | His | Pro | Phe | Stewart et al., 1981 | ||
| angiotensin-1 | P01019 | 34-43 | Asp-Arg+Val-Tyr-Ile-His-Pro-Phe-His-Leu | P | LC | - | - | Asp | Arg | Val | Tyr | Ile | His | Stewart et al., 1981 | ||
| angiotensin-2 | P01019 | 34-41 | Asp-Arg-Val+Tyr-Ile-His-Pro-Phe | P | LC | - | Asp | Arg | Val | Tyr | Ile | His | Pro | Stewart et al., 1981 | ||
| angiotensin-2 | P01019 | 34-41 | Asp-Arg+Val-Tyr-Ile-His-Pro-Phe | P | LC | - | - | Asp | Arg | Val | Tyr | Ile | His | Stewart et al., 1981 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Arg14+Ile-peptide | P | Arg | Met | Asp | Arg | Ile | Gly | Ala | Gln | Vanneste et al., 1988 | 3284 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Gly16+Ala-peptide | P | Asp | Arg | Ile | Gly | Ala | Gln | Ser | Gly | Vanneste et al., 1988 | 3285 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Gly20+Leu-peptide | P | Ala | Gln | Ser | Gly | Leu | Gly | Cys | Asn | Vanneste et al., 1988 | 3286 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Arg11+Met-peptide | P | Phe | Gly | Gly | Arg | Met | Asp | Arg | Ile | Vanneste et al., 1988 | 3267 | ||
| atrial natriuretic factor | P01160 | 124-151 | Ser-Leu-Arg-Arg+Ser-peptide | P | Ser | Leu | Arg | Arg | Ser | Ser | Cys | Phe | Vanneste et al., 1988 | 3266 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Cys7+Phe-peptide | P | Arg | Ser | Ser | Cys | Phe | Gly | Gly | Arg | Vanneste et al., 1988 | 3254 | ||
| atrial natriuretic factor | P01160 | 124-151 | peptide-Ser25+Phe-Arg-Tyr | P | Gly | Cys | Asn | Ser | Phe | Arg | Tyr | - | Vanneste et al., 1988 | 3287 | ||
| beta-amyloid protein 42 | P05067 | 672-713 | peptide-Val689+Phe-peptide | P | Gln | Lys | Leu | Val | Phe | Phe | Ala | Glu | Yan et al., 2006 | |||
| beta-amyloid protein 42 | P05067 | 672-713 | Asp-Ala+Phe-peptide | P | MS | - | Asp | Ala | Glu | Phe | Arg | His | Asp | Yan et al., 2006 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | P | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Matsas et al., 1984 | 24364 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly+Phe-Ser-Pro-Phe-Arg | N | Arg | Pro | Pro | Gly | Phe | Ser | Pro | Phe | Matsas et al., 1984 | 24363 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Ser120+Met-peptide | P | Arg | Ile | Gly | Ser | Met | Ser | Gly | Leu | Watanabe et al., 1997 | 3264 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Lys114+Leu-peptide | P | Phe | Gly | Leu | Lys | Leu | Asp | Arg | Ile | Watanabe et al., 1997 | 3262 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Arg117+Ile-peptide | P | Lys | Leu | Asp | Arg | Ile | Gly | Ser | Met | Watanabe et al., 1997 | 3263 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Gly112+Leu-peptide | P | Gly | Cys | Phe | Gly | Leu | Lys | Leu | Asp | Watanabe et al., 1997 | 3261 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Cys110+Phe-peptide | P | Ser | Lys | Gly | Cys | Phe | Gly | Leu | Lys | Watanabe et al., 1997 | 3260 | ||
| C-type natriuretic peptide | P23582 | 105-126 | peptide-Gly123+Leu-peptide | P | Ser | Met | Ser | Gly | Leu | Gly | Cys | - | Watanabe et al., 1997 | 3265 | ||
| caspase-9 precursor | Q53Y70 | 1-416 | peptide-Asp330+Ala-peptide | P | Asp | Gln | Leu | Asp | Ala | Ile | Ser | Ser | 3084 | |||
| chemotactic peptide | formyl-Met+Leu-Phe | N | - | - | For | Met | Leu | Phe | - | - | Turner, 2004 | |||||
| cholecystokinin-8 | P06307 | 96-103 | Asp-Tyr-Met-Gly+Trp-Met-Asp-Phe-NH2 | P | Asp | Tyr | Met | Gly | Trp | Met | Asp | Phe | Turner, 2004 | |||
| cholecystokinin-8 | P06307 | 96-103 | Asp-Tyr-Met-Gly-Trp-Met-Asp+Phe-NH2 | N | Gly | Trp | Met | Asp | Phe | NH2 | - | - | Turner, 2004 | |||
| consensus-glycyl bond | peptide-Gly+Phe-peptide | N | NPe | Phe | Phe | Gly | Phe | Leu | Ala | CPe | Turner, 2004 | |||||
| corticotropin | P01189 | 138-176 | Ser138+Tyr-peptide | P | MS | - | - | - | Ser | Tyr | Ser | Met | Glu | Scholzen et al., 2007 | 24271 | |
| corticotropin | P01189 | 138-176 | peptide-Met141+Glu-peptide | P | MS | Ser | Tyr | Ser | Met | Glu | His | Phe | Arg | Scholzen et al., 2007 | 24276 | |
| corticotropin | P01189 | 138-176 | peptide-Pro156+Val-peptide | P | MS | Lys | Arg | Arg | Pro | Val | Lys | Val | Tyr | Scholzen et al., 2007 | 24280 | |
| corticotropin | P01189 | 138-176 | peptide-Lys158+Val-peptide | P | MS | Arg | Pro | Val | Lys | Val | Tyr | Pro | Asn | Scholzen et al., 2007 | 24281 | |
| corticotropin | P01189 | 138-176 | peptide-Arg154+Arg-peptide | P | MS | Gly | Lys | Lys | Arg | Arg | Pro | Val | Lys | Scholzen et al., 2007 | ||
| corticotropin | P01189 | 138-176 | peptide-Pro149+Val-peptide | P | MS | Trp | Gly | Lys | Pro | Val | Gly | Lys | Lys | Scholzen et al., 2007 | ||
| corticotropin | P01189 | 138-176 | peptide-Asn162+Gly-peptide | P | MS | Val | Tyr | Pro | Asn | Gly | Ala | Glu | Asp | Scholzen et al., 2007 | ||
| corticotropin | P01189 | 138-176 | peptide-Trp146+Gly-peptide | P | MS | His | Phe | Arg | Trp | Gly | Lys | Pro | Val | Scholzen et al., 2007 | ||
| dynorphin-(1-9) | P01213 | 207-215 | Tyr-Gly-Gly+Phe-Leu-Arg-Arg-Ile-Arg | N | - | Tyr | Gly | Gly | Phe | Leu | Arg | Arg | Matsas et al., 1984 | 24366 | ||
| dynorphin-(1-9) | P01213 | 207-215 | peptide-Phe210+Leu-peptide | P | Tyr | Gly | Gly | Phe | Leu | Arg | Arg | Ile | Matsas et al., 1984 | 24367 | ||
| dynorphin-(1-9) | P01213 | 207-215 | peptide-Arg213+Ile-peptide | P | Phe | Leu | Arg | Arg | Ile | Arg | - | - | Matsas et al., 1984 | 24368 | ||
| endothelin-1 | P05305 | 53-73 | peptide-Ser57+Leu-peptide | P | NT | Ser | Cys | Ser | Ser | Leu | Met | Asp | Lys | Vijayaraghavan et al., 1990 | ||
| endothelin-1 | P05305 | 53-73 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu+Ile-peptide | P | NT | Cys | His | Leu | Asp | Ile | Ile | Trp | - | Vijayaraghavan et al., 1990 | ||
| endothelin-1 | P05305 | 53-70 | Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His+Leu-Asp | P | NT | Tyr | Phe | Cys | His | Leu | Asp | - | - | Vijayaraghavan et al., 1990 | ||
| endothelin-2 | P20800 | 49-69 | Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu+Ile-peptide | P | NT | Cys | His | Leu | Asp | Ile | Ile | Trp | - | Vijayaraghavan et al., 1990 | ||
| endothelin-2 [1-18] | P20800 | 49-67 | Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His+Leu-Asp-Ile | P | NT | Tyr | Phe | Cys | His | Leu | Asp | Ile | - | Vijayaraghavan et al., 1990 | ||
| endothelin-3 | P14138 | 97-117 | Cys-Thr+Phe-peptide | P | NT | - | Cys | Thr | Cys | Phe | Thr | Tyr | Lys | Vijayaraghavan et al., 1990 | ||
| endothelin-3 | P14138 | 97-117 | peptide-Cys107+Val-peptide | P | NT | Asp | Lys | Glu | Cys | Val | Tyr | Tyr | Cys | Vijayaraghavan et al., 1990 | ||
| endothelin-3 | P14138 | 97-117 | Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu+Ile-peptide | P | NT | Cys | His | Leu | Asp | Ile | Ile | Trp | - | Vijayaraghavan et al., 1990 | ||
| endothelin-3 [1-16] | P14138 | 97-114 | Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His+Leu-Asp | P | NT | Tyr | Tyr | Cys | His | Leu | Asp | - | - | Vijayaraghavan et al., 1990 | ||
| gastrin | P01350 | 76-92 | peptide-Trp79+Leu-peptide | P | Gln | Gly | Pro | Trp | Leu | Glu | Glu | Glu | Pauwels et al., 1989 | 3275 | ||
| gastrin | P01350 | 76-92 | peptide-Ala86+Tyr-peptide | P | Glu | Glu | Glu | Ala | Tyr | Gly | Trp | Met | Pauwels et al., 1989 | 3276 | ||
| gastrin | P01350 | 76-92 | peptide-Gly88+Trp-peptide | P | Glu | Ala | Tyr | Gly | Trp | Met | Asp | Phe | Pauwels et al., 1989 | 3277 | ||
| gastrin | P01350 | 76-92 | peptide-Asp91+Phe-peptide | P | Gly | Trp | Met | Asp | Phe | Gly | Arg | Arg | Pauwels et al., 1989 | 3278 | ||
| glucagon | P01275 | 98-128 | peptide-Asp106+Val-peptide | P | MS | Phe | Thr | Ser | Asp | Val | Ser | Ser | Tyr | Hupe-Sodmann et al., 1995 | ||
| glucagon | P01275 | 98-128 | peptide-Ser109+Tyr-peptide | P | MS | Asp | Val | Ser | Ser | Tyr | Leu | Glu | Gly | Hupe-Sodmann et al., 1995 | ||
| glucagon | P01275 | 98-128 | peptide-Tyr110+Leu-peptide | P | MS | Val | Ser | Ser | Tyr | Leu | Glu | Gly | Gln | Hupe-Sodmann et al., 1995 | ||
| glucagon | P01275 | 98-128 | peptide-Glu118+Phe-peptide | P | MS | Ala | Ala | Lys | Glu | Phe | Ile | Ala | Trp | Hupe-Sodmann et al., 1995 | ||
| glucagon | P01275 | 98-128 | peptide-Phe119+Ile-peptide | P | MS | Ala | Lys | Glu | Phe | Ile | Ala | Trp | Leu | Hupe-Sodmann et al., 1995 | ||
| glucagon | P01275 | 98-128 | peptide-Trp122+Leu-peptide | P | MS | Phe | Ile | Ala | Trp | Leu | Val | Lys | Gly | Hupe-Sodmann et al., 1995 | ||
| glucagon-like peptide 1 (28-36) amide | P01275 | 119-127 | Phe-Ile-Ala-Trp+Leu-Val-Lys-Gly-Arg-Gly-Arg-Arg-Asp-Phe-Pro-Glu-Glu-Val | P | NT | Phe | Ile | Ala | Trp | Leu | Val | Lys | Gly | Gao et al., 2021 | ||
| Gonadoliberin-1 | P01148 | 24-33 | Peptide-Gly29+Leu-Arg-Pro-Gly | N | NT | Trp | Ser | Tyr | Gly | Leu | Arg | Pro | Gly | Rose et al., 2002 | ||
| Gonadoliberin-1 | P01148 | 24-33 | Gln-His-Trp-Ser27+Tyr-Peptide | N | NT | Gln | His | Trp | Ser | Tyr | Gly | Leu | Arg | Rose et al., 2002 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His+Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Val | Asn | Gln | His | Leu | Cya | Gly | Ser | Kerr & Kenny, 1974 | 19604 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His+Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Cya | Gly | Ser | His | Leu | Val | Glu | Ala | Kerr & Kenny, 1974 | 19605 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu+Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Gly | Ser | His | Leu | Val | Glu | Ala | Leu | Kerr & Kenny, 1974 | 19606 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala+Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Val | Kerr & Kenny, 1974 | 19607 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu+Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Val | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Kerr & Kenny, 1974 | 19608 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Kerr & Kenny, 1974 | 19609 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu+Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Glu | Kerr & Kenny, 1974 | 19610 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly+Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Gly | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Kerr & Kenny, 1974 | 19611 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe+Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Kerr & Kenny, 1974 | 19612 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe+Tyr-Thr-Pro-Lys-Ala | N | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Lys | Kerr & Kenny, 1974 | 19613 | ||
| lamina-associated polypeptide 2, isoform alpha | P42166 | 33-37 | Arg-Lys-Asp+Val-Tyr | P | LC | - | Arg | Lys | Asp | Val | Tyr | - | - | Guerin et al., 1997 | ||
| locustatachykinin-1 | P16223 | 1-9 | Gly-Pro-Ser-Gly+Phe-Tyr-Gly-Val-Arg-NH2 | N | MS | Gly | Pro | Ser | Gly | Phe | Tyr | Gly | Val | Bland et al., 2007 | ||
| Melanin-concentrating hormone | P14200 | 147-165 | peptide-Cys153+Met-peptide | P | NT | Met | Leu | Arg | Cys | Met | Leu | Gly | Arg | Checler et al., 1992 | ||
| Melanin-concentrating hormone | P14200 | 147-165 | peptide-Arg157+Val-peptide | P | NT | Met | Leu | Gly | Arg | Val | Tyr | Arg | Pro | Checler et al., 1992 | ||
| Melanin-concentrating hormone | P14200 | 147-165 | peptide-Cys162+Trp-Gln-Val | P | NT | Tyr | Arg | Pro | Cys | Trp | Gln | Val | - | Checler et al., 1992 | ||
| melanotropin alpha | P01189 | 138-150 | peptide-Pro149+Val | P | MS | Trp | Gly | Lys | Pro | Val | - | - | - | Scholzen et al., 2007 | 24270 | |
| melanotropin alpha | P01189 | 138-150 | peptide-His143+Phe-peptide | P | MS | Ser | Met | Glu | His | Phe | Arg | Trp | Gly | Scholzen et al., 2007 | 24272 | |
| melanotropin alpha | P01189 | 138-150 | peptide-Arg145+Trp-peptide | P | MS | Glu | His | Phe | Arg | Trp | Gly | Lys | Pro | Scholzen et al., 2007 | 24273 | |
| melanotropin alpha | P01189 | 138-150 | peptide-Phe144+Arg-peptide | P | MS | Met | Glu | His | Phe | Arg | Trp | Gly | Lys | Scholzen et al., 2007 | 24274 | |
| melanotropin alpha | P01189 | 138-150 | peptide-Glu142+His-peptide | P | MS | Tyr | Ser | Met | Glu | His | Phe | Arg | Trp | Scholzen et al., 2007 | 24275 | |
| natriuretic peptides B | P16860 | 103-134 | peptide-Met106+Val-peptide | P | Ser | Pro | Lys | Met | Val | Gln | Gly | Ser | Watanabe et al., 1997 | |||
| natriuretic peptides B | P16860 | 103-134 | peptide-Arg119+Ile-peptide | P | Lys | Met | Asp | Arg | Ile | Ser | Ser | Ser | Watanabe et al., 1997 | |||
| Neuropeptide PDF | O96690 | 83-100 | peptide-Ser89+Leu-peptide | P | MS | Leu | Ile | Asn | Ser | Leu | Leu | Ser | Leu | Isaac et al., 2007 | ||
| neurotensin | P30990 | 151-163 | Glp-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro+Tyr-Ile-Leu | N | Pro | Arg | Arg | Pro | Tyr | Ile | Leu | - | Turner, 2004 | 17013 | ||
| neurotensin | P30990 | 151-163 | Glp-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Leu | N | Arg | Arg | Pro | Tyr | Ile | Leu | - | - | Turner, 2004 | 17012 | ||
| Oxytocin | P01178 | 20-28 | peptide-Pro26+Leu-Gly-NH2 | P | Gln | Asn | Cys | Pro | Leu | Gly | NH2 | - | Johnson et al., 1984 | |||
| physalaemin | P08615 | 1-11 | peptide-Lys6+Phe-peptide | P | Asp | Pro | Asn | Lys | Phe | Tyr | Gly | Leu | Matsas et al., 1984 | 24359 | ||
| physalaemin | P08615 | 1-11 | peptide-Phe7+Tyr-peptide | P | Pro | Asn | Lys | Phe | Tyr | Gly | Leu | Met | Matsas et al., 1984 | 24360 | ||
| physalaemin | P08615 | 1-11 | peptide-Gly9+Leu-peptide | P | Lys | Phe | Tyr | Gly | Leu | Met | NH2 | - | Matsas et al., 1984 | 24361 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys+Trp-Ala-Leu-Ser-Arg | P | Lys | Trp | Asn | Lys | Trp | Ala | Leu | Ser | Nagatomo et al., 1996 | 3271 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp+Ala-Leu-Ser-Arg | P | Trp | Asn | Lys | Trp | Ala | Leu | Ser | Arg | Nagatomo et al., 1996 | 3272 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala+Leu-Ser-Arg | P | Asn | Lys | Trp | Ala | Leu | Ser | Arg | Gly | Nagatomo et al., 1996 | 3273 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys+Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg | P | Phe | Arg | Lys | Lys | Trp | Asn | Lys | Trp | Nagatomo et al., 1996 | 3270 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg+Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg | P | - | - | Ala | Arg | Leu | Asp | Val | Ala | Nagatomo et al., 1996 | 3268 | ||
| proadrenomedullin N-terminal 20 peptide (PAMP) | P35318 | 22-41 | Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu+Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg | P | Val | Ala | Ser | Glu | Phe | Arg | Lys | Lys | Nagatomo et al., 1996 | 3269 | ||
| substance P | P20366 | 58-68 | Arg-Pro-Lys-Pro-Gln-Gln+Phe-Phe-Gly-Leu-Met-NH2 | P | Lys | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Matsas et al., 1984 | 17014 | ||
| substance P | P20366 | 58-68 | Arg-Pro-Lys-Pro-Gln-Gln-Phe+Phe-Gly-Leu-Met-NH2 | N | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Met | Turner, 2004 | 17015 | ||
| substance P | P20366 | 58-68 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly+Leu-Met-NH2 | N | Gln | Phe | Phe | Gly | Leu | Met | NH2 | - | Matsas et al., 1984 | |||
| substance P (deamidated) | Arg-Pro-Lys-Pro-Gln-Gln+Phe-Phe-Gly-Leu-Met | S | Lys | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Matsas et al., 1984 | |||||
| Suc-Ala-Ala-Leu-NHPhNO2 | Suc-Ala-Ala+Leu-NHPhNO2 | S | - | Suc | Ala | Ala | Leu | NAN | - | - | Turner, 2004 | |||||
| succinyl-Ala-Ala-Phe-NHMec | succinyl-Ala-Ala+Phe-NHMec | S | - | Suc | Ala | Ala | Phe | AMC | - | - | Fisk et al., 2007 | |||||
| thimet oligopeptidase inhibitor | Cpp-Ala-Ala+Phe-pAb | N | - | NBk | Ala | Ala | Phe | pAb | - | - | Barrett & Chen, 2004 | |||||
| [D-Ala2,Leu5]-enkephalin | Tyr-D-Ala-Gly+Phe-Leu | N | - | Tyr | DAl | Gly | Phe | Leu | - | - | Matsas et al., 1984 | |||||
| [D-Ala2,Leu5]-enkephalinamide | Tyr-D-Ala-Gly+Phe-Leu-NH2 | N | - | Tyr | DAl | Gly | Phe | Leu | NH2 | - | Matsas et al., 1984 | |||||
| [Des-Tyr1, Met5]enkephalin | P01210 | 101-104 | Gly-Gly102+Phe-Met | N | NT | - | - | Gly | Gly | Phe | Met | - | - | Rose et al., 2002 | ||
| [Leu5]-enkephalin | P01213 | 175-179 | Tyr-Gly-Gly+Phe-Leu-NH2 | N | - | Tyr | Gly | Gly | Phe | Leu | - | - | Matsas et al., 1984 | |||
| [Leu5]-enkephalin-Arg6 | Tyr-Gly-Gly+Phe-Leu-Arg | N | - | Tyr | Gly | Gly | Phe | Leu | Arg | - | Matsas et al., 1984 | |||||
| [Leu5]-enkephalin-Arg6 | Tyr-Gly-Gly-Phe+Leu-Arg | N | Tyr | Gly | Gly | Phe | Leu | Arg | - | - | Matsas et al., 1984 | |||||
| [Leu5]-enkephalinamide | Tyr-Gly-Gly+Phe-Leu-NH2 | N | - | Tyr | Gly | Gly | Phe | Leu | NH2 | - | Matsas et al., 1984 | |||||
| [Met5]-enkephalin | Tyr-Gly-Gly+Phe-Met | N | - | Tyr | Gly | Gly | Phe | Met | - | - | Matsas et al., 1984 | |||||
| [Met5]-enkephalin-Arg6 | Tyr-Gly-Gly+Phe-Met-Arg | N | - | Tyr | Gly | Gly | Phe | Met | Arg | - | Matsas et al., 1984 | |||||
| [Met5]-enkephalin-Arg6-Phe7 | Tyr-Gly-Gly+Phe-Met-Arg-Phe | N | - | Tyr | Gly | Gly | Phe | Met | Arg | Phe | Matsas et al., 1984 | |||||
| [Nle11]-substance P | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly+Leu-Nle-NH2 | N | Gln | Phe | Phe | Gly | Leu | Nle | NH2 | - | Matsas et al., 1984 | |||||
| [Nle11]-substance P | Arg-Pro-Lys-Pro-Gln-Gln+Phe-Phe-Gly-Leu-Nle-NH2 | S | Lys | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Matsas et al., 1984 | |||||
| [Nle11]-substance P | Arg-Pro-Lys-Pro-Gln-Gln-Phe+Phe-Gly-Leu-Nle-NH2 | S | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Met | Matsas et al., 1984 |
